Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes (scientific article published on 15 May 2017)

Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro

Q24540945

Myeloid-related protein-8/14 is critical for the biological response to vascular injury

Q24627504

Thrombocytosis

Q28167883

Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin

Q28219365

Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis

Q28512072

Hepatic thrombopoietin mRNA is increased in acute inflammation

Q28575389

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Q29618673

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Q29619529

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Q30310323

Postprandial glucose regulation: new data and new implications

Q31033684

Evaluation of platelet function by flow cytometry

Q33332950

Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization

Q33498092

Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008

Q33602366

Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity

Q33724394

Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis

Q33788714

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

Q33813768

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Q34673134

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

Q34770384

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people

Q35004093

ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice

Q35370268

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

Q35546626

Paraneoplastic thrombocytosis in ovarian cancer.

Q35812402

The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004.

Q35898176

New gene functions in megakaryopoiesis and platelet formation

Q35909375

Postprandial hyperglycemia and diabetes complications: is it time to treat?

Q35992276

Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal

Q36113963

Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages

Q36360437

Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells

Q36534480

Disordered haematopoiesis and athero-thrombosis.

Q36773876

Antiplatelet therapy for every diabetic person?

Q36783726

Comparison of platelet activity measurements by use of arterial and venous blood sampling.

Q37252227

Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy.

Q37257153

Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions

Q37428365

Postprandial hyperglycemia as an etiological factor in vascular failure

Q37464262

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions

Q37486465

Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis

Q37711215

Sterile inflammation in the liver

Q38043897

Methods of accelerated atherosclerosis in diabetic patients

Q38100100

Immune surveillance by the liver

Q38139201

Role of multiligand/RAGE axis in platelet activation.

Q38167989

Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.

Q38292693

Platelets and Antiplatelet Therapy in Patients with Coronary Artery Disease and Diabetes

Q38737304

Comparison of Immature Platelet Count to Established Predictors of Platelet Reactivity During Thienopyridine Therapy

Q39601673

Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging stu

Q39680831

Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets.

Q40473509

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

Q40772902

Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis

Q42157999

Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance

Q42382293

Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin i

Q43064031

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice

Q43489161

Mean platelet volume is associated with glycaemic control and retinopathy in patients with type 2 diabetes mellitus

Q44068825

Mean platelet volume in Type 2 diabetic patients

Q44897498

Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia

Q45871280

Platelet reactivity and response to aspirin in subjects with the metabolic syndrome

Q46210875

Mean platelet volume in patients with type 2 diabetes mellitus

Q46374398

Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease

Q46418067

The relationship between glycemic control and platelet activity in type 2 diabetes mellitus

Q46688711

Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.

Q46849874

Deficiency of ATP-binding cassette transporter B6 in megakaryocyte progenitors accelerates atherosclerosis in mice

Q46935048

IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections

Q47936593

Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction

Q49031698

Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes.

Q51446902

Large Platelets Circulate in an Activated State in Diabetes Mellitus

Q51609166

The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes.

Q53144772

Are Immature Platelets Growing Up?: Toward a New Marker of Antiplatelet Drug Resistance.

Q53777597

Thrombopoietin production in wild-type and interleukin-6 knockout mice with acute inflammation.

Q54653713

Dynamic Visualization of Thrombopoiesis Within Bone Marrow

Q58450371

Mean Platelet Volume May Represent a Predictive Parameter for Overall Vascular Mortality and Ischemic Heart Disease

Q61842061

Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy

Q70054580

Increased platelet volume in manifest diabetic rats

Q71779786

Platelet factor 4, beta-thromboglobulin and thrombospondin levels in type I diabetes mellitus patients

Q72036013

Vascular disease outcome and thrombocytosis in diabetic and nondiabetic end-stage renal disease patients on peritoneal dialysis

Q72905466

Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice

Q81332054

Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease

Q85212433

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

2133-2147

P577

publication date

2017-05-15

P1433

published in

Journal of Clinical Investigation

Q3186904

P1476

title

Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes

P478

volume

127

Reverse relations

cites work (P2860)

Q89810882	Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic Serum-induced Glomerulonephritis by Affecting Macrophage Characterization through Intraglomerular Crosstalk
Q52311658	Anti-Diabetic Effects of Dung Beetle Glycosaminoglycan on db Mice and Gene Expression Profiling.
Q58111743	Arterial Thrombosis Is Accompanied by Elevated Mitogen-Activated Protein Kinase (MAPK) and Cyclooxygenase-2 (COX-2) Expression via Toll-Like Receptor 4 (TLR-4) Activation by S100A8/A9
Q99352855	Association of rs2070600 in advanced glycosylation end-product specific receptor with prognosis of heart failure
Q90318136	DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Q89113492	Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis
Q98563109	Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Q57300007	Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?
Q49834393	Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function
Q91825128	Hepatic gene expression explains primary drug toxicity in bipolar disorder
Q50324081	Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults
Q92679527	Impact of diabetes mellitus on immature platelet fraction and its association with coronary artery disease
Q91795685	Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Q102142948	Inhibition of interleukin-1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis
Q55444585	Integrated Network Pharmacology and Metabolomics Analysis of the Therapeutic Effects of Zi Dian Fang on Immune Thrombocytopenic Purpura.
Q40172258	It's reticulated: Diabetes, atherosclerosis, and reticulated platelets
Q57178397	It's reticulated: the liver at the heart of atherosclerosis
Q49681927	Leptin-deficient obesity prolongs survival in a murine model of myelodysplastic syndrome.
Q89967822	Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes
Q64966156	Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis.
Q88956893	Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology
Q58079436	Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration
Q52668399	Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Q93040081	Neutrophils as regulators of cardiovascular inflammation
Q89976291	Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes
Q93081056	Platelet biology and functions: new concepts and clinical perspectives
Q60044321	Prognostic values of S100 family members in ovarian cancer patients
Q94464323	Prospect of Sodium-Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes
Q90643374	Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models
Q50098255	Reticulated platelets in poorly controlled diabetes: A new era in the management of residual risk?
Q90467790	S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis
Q55274411	S100A8/A9 in Inflammation.
Q47614541	Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials
Q47745185	Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity
Q51001666	Sugar makes neutrophils RAGE: linking diabetes-associated hyperglycemia to thrombocytosis and platelet reactivity.
Q98465714	The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Q94517853	The predictive role of serum calprotectin on mortality in hemodialysis patients with high phosphoremia
Q48512017	Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
Q60047032	Vascular Oxidative Stress: Impact and Therapeutic Approaches
Q52660853	Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy.
Q90245131	[Value of S100A8 in evaluating the prognosis of children with acute lymphoblastic leukemia]